Abstract:Background Alternative splicing of VEGF-A gives rise to two families – the pro-angiogenic VEGFxxx family and the anti-angiogenic VEGFxxxb family that differ by only six amino acids at their C-terminal end. The first verified and widely reported VEGFxxxb family member is VEGF165b, and here VEGF165b is a positive control. Methords VEGF111b mRNA was detected in ovarian cancer cell lines SKOV3 and OVCAR3 by RT-PCR. Western blot was used to detect VEGF111b and VEGF165b protein in the CMs and lysates of OVCAR3 cells. MTT and colony formation assay were used to detect the short-term and long-term proliferation inhibition ability of ovarian cancer cells with VEGF111b overexpression. Cell-cycle analysis was performed to further characterize VEGF111b inhibition effects. VEGF111b signaling on ovarian cancer cells were determined by western blot. The expression levels of Ki67, PCNA, CD31 and VEGF in VEGF111b overexpression xenograft model were detected by immunohistochemistry. Results Under the effect of mitomycin C, we identify a new member of VEGFxxxb family-VEGF111b in ovarian cancer cell lines. SKOV3 and OVCAR cells were transfected with empty lentivirus, VEGF111b or VEGF165b lentivirus. VEGF111b and VEGF165b overexpression inhibits proliferation of the ovarian cancer cells, but inhibition effect of VEGF111b is slightly less efficient than VEGF165b. Cell cycle analysis was further used to elucidate the mechanism involved in the inhibition effect. Further, we detected the expression of VEGF-R2 in SKOV3 and OVCAR3 cells, and shown that VEGF111b might bind to conventional VEGF-R2 with the results of reducing VEGF-R2 tyrosine phosphorylation and downstream signaling to have anti-tumor effects. In vivo VEGF111b overexpression inhibits ovarian cancer growth in xenograft mice. Conclusion Our results show that VEGF111b, as a new member of VEGFxxxb family, with similar properties to VEGF165b, plays potent anti-tumor effect in vitro and in vivo that can target the VEGF-R2 and its signaling pathway to inhibit ovarian tumor growth. This also opens a new avenue for treating ovarian cancer.

Construction of VEGF111b expression vector and preparation of VEGF111b antibody

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction of pcDNA3-Endo eukaryon expression plasmid and angiogenesis inhibition in vitro

Cloning of human vascular endothelial growth factor cDNA and its expression in COS-7 cells

Cloning, Construction of Prokaryotic Expression System and Identification of Vibrio Vulni Ficus Vvha Gene

Prokaryotic Expression of VEGF165 and Preliminary Screening of Anti-VEGF Hybridoma Cell Lines

Recombinant Human Vascular Endothelial Growth Factor-C and Its Expression in vitro

Cloning, Expression and Activity Detection of Vascular Endothelial Growth Factor

PREPARATION OF RECOMBINANT PROTEIN OF EXTRACELLULAR LIGAND BINDING DOMAINS OF MOUSE VEGF RECEPTOR 2 AND ITS APPLICATION

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Cloning,purification and Activity of Mutant Human Vascular Endothelial Growth Factor(hvegf)

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Molecular Cloning, Expression And Characterization Of Recombinant Human Vascular Endothelial Growth Factor 121

Construction of human eukaryotic expression plasmid vascular endothelial growth factor 165 and its expression in transfected vascular smooth muscles.

Gene cloning of secreted VEGF receptor flt-1 (I similar to IV extracellular domain) and the corresponding recombinant adenovirus construction and expression

VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth

Cloning and Construction of Adenovirus Expressing Human Angiopoietin-1 or Vascular Endothelial Growth Factor

The construction of a DNAvaccine targeting extracellular region of PDGF-R-2β gene

Construction of Targeting-VEGF shRNA Plasmid and Observation of its Inhibitory Effect on Tca8113 Cells

Construction and Expression of a Lentivirus Expression Vector Carrying the VEGF165-EGFP Fusion Gene in Breast Cancer MCF-7 Cells.

Construction and Identification of Eukaryotic Expression Vector Pcdna3.1 (+)-ABCG2